Anika Therapeutics Inc (ANIK.OQ)

ANIK.OQ on NASDAQ Stock Exchange Global Select Market

41.08USD
20 Aug 2014
Price Change (% chg)

$-0.19 (-0.46%)
Prev Close
$41.27
Open
$40.99
Day's High
$41.08
Day's Low
$40.47
Volume
5,271
Avg. Vol
99,097
52-wk High
$52.48
52-wk Low
$22.15

ANIK.OQ

Chart for ANIK.OQ

About

Anika Therapeutics, Inc. (Anika) develops, manufactures and commercializes therapeutic products for tissue protection, healing and repair. These products are based on hyaluronic acid (HA), a naturally occurring, biocompatible polymer found throughout the body. As of December 31, 2011, Anika’s wholly owned subsidiary, Anika... (more)

Overall

Beta: 1.74
Market Cap (Mil.): $597.86
Shares Outstanding (Mil.): 14.49
Dividend: --
Yield (%): --

Financials

  ANIK.OQ Industry Sector
P/E (TTM): 17.62 148.68 33.74
EPS (TTM): 2.34 -- --
ROI: 23.30 -3.09 18.03
ROE: 25.51 -6.73 18.77
Search Stocks

FDA approves Anika Therapeutics arthritis drug; shares soar

- Anika Therapeutics Inc said the U.S. Food and Drug Administration approved its drug to treat pain and improve joint mobility in patients with osteoarthritis of the knee, more than four years after it first filed for approval.

25 Feb 2014

UPDATE 1-FDA approves Anika Therapeutics arthritis drug; shares soar

(Adds details, background, analyst comment; adds share movement)

25 Feb 2014

FDA approves Anika Therapeutics arthritis drug

Feb 25 - Anika Therapeutics Inc said the U.S. Food and Drug Administration approved its drug to treat pain and improve joint mobility in patients with osteoarthritis of the knee.

25 Feb 2014

Competitors

  Price Change
Johnson & Johnson (JNJ.N) $102.96 0.00
Novartis AG (NOVN.VX) CHF80.70 +0.40
Pfizer Inc. (PFE.N) $28.87 -0.07
Roche Holding Ltd. (ROG.VX) CHF266.10 +0.70
Merck & Co., Inc. (MRK.N) $59.32 +0.41
Bayer AG (BAYGn.DE) €95.41 -2.28
Bayer AG (BAYE.F) -- --
Sanofi SA (SASY.PA) €79.23 -0.52
Abbott Laboratories (ABT.N) $42.30 -0.24
Amgen, Inc. (AMGN.OQ) $132.79 -0.23

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: New Constructs, LLC
$25.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00
Provider: S&P Capital IQ Quantitative Report
$127.00
Provider: Pechala's Reports
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks